BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
Pharmacogenetics
,
Doxorubicin
,
rs4950928
,
IL1A
,
nitric oxide metabolic process
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
edil3 protein, human
(compound)
Summary
General Info
Genetic Markers
Most Correlated Genes
KAT5
MYCN
TMEM132E
HPD
ATP13A5-AS1
Explore Genetic Markers Results
Pathway Enrichment
Most Correlated Biogroups
cytosol
organic cyclic compound binding
heterocyclic compound binding
regulation of nitrogen compound metabolic process
nucleoplasm
Explore Pathway Enrichment Results
Curated Studies
Most Correlated Studies
Endothelial cells cultured from human umbilical veins on DEL1/EDIL3 protein-coated plates
Explore Curated Studies Results
Literature
Most Relevant Literature
EDIL3 is a potential prognostic biomarker that correlates with immune infiltrates in gastric cancer.
Dysregulation of the Skin-Liver Axis in Prurigo Nodularis: An Integrated Genomic, Transcriptomic, an…
Del-1 in Psoriasis Induced the Expression of αvβ3 and α5β1 in Endothelial Cells.
Highly sensitive fluorescent detection of EDIL3 overexpressed exosomes for the diagnosis of triple-n…
Astrocytic APOE4 genotype-mediated negative impacts on synaptic architecture in human pluripotent st…
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
There were no clinical trials for edil3 protein, human
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ